Rappta Therapeutics is a lead-optimization stage biopharmaceutical company. We are working on a first-in-class series of anti-cancer molecules that reactivate a key tumor suppressor, protein phosphatase 2A (PP2A).
Location: Finland, Mainland Finland, Helsinki
Member count: 11-50
Total raised: $10.568701M
Founded date: 2019
Investors 1
| Date | Name | Website |
| - | Advent Lif... | adventls.c... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 13.10.2020 | Series A | $10.568701... | - | finsmes.co... |
Mentions in press and media 1
| Date | Title | Description | Category | Author | Source |
| 13.10.2020 | Rappta The... | Rappta Therapeutics, a Helsink... | Finland | - | finsmes.co... |